Myopic degeneration is a progressive eye condition in which severe nearsightedness physically damages the structures at the back of the eye, leading to permanent vision loss. It typically develops in people with a prescription of -6.00 diopters or higher, where the eyeball has stretched so long that the retina, the light-sensitive tissue lining the back of the eye, begins to thin, crack, and break down. Unlike ordinary nearsightedness, which glasses or contacts can correct, myopic degeneration causes structural harm that corrective lenses cannot fix.
How It Differs From Regular Nearsightedness
Most people with nearsightedness simply have eyes that are slightly longer than average, causing distant objects to look blurry. Glasses, contacts, or laser surgery correct the problem, and the eye itself stays healthy. High myopia, generally a prescription of -6.00 diopters or more, raises the stakes because the eyeball is significantly elongated, often measuring more than 26.5 millimeters from front to back (a normal eye is roughly 24 mm). But even high myopia doesn’t guarantee damage.
Myopic degeneration is the point at which that elongation starts to physically injure the eye. The stretching thins the retina and the layer of blood vessels beneath it (the choroid), and eventually causes structural lesions that threaten central vision. One hallmark finding, called a posterior staphyloma, is an outward bulging of the eye wall that is unique to this condition and not seen in any other form of nearsightedness. Researchers have classified at least 10 types of staphyloma based on shape and location.
What Happens Inside the Eye
As the eye continues to stretch, the membrane separating the retina from the blood vessel layer (Bruch’s membrane) develops tiny mechanical breaks known as lacquer cracks. These appear as irregular yellow lines in the central retina. Fresh lacquer cracks can bleed, and over time they act as weak points where abnormal new blood vessels can push through into the retina.
That blood vessel invasion is one of the most sight-threatening complications. The theory behind it is straightforward: excessive elongation creates mechanical stress on the retina, which throws off the balance of chemical signals controlling blood vessel growth. New, fragile vessels sprout where they shouldn’t be, leak fluid and blood into the macula (the area responsible for sharp central vision), and directly damage the light-detecting cells. This process unfolds in stages, each associated with worsening vision loss. Over time, the sites where these vessels formed leave behind pigmented gray scars called Fuchs’ spots.
How the Damage Progresses
A long-term study tracking the natural history of myopic maculopathy found a fairly consistent sequence of changes. The earliest sign is a “tessellated” appearance to the back of the eye, meaning you can see the underlying blood vessel pattern because the retina has thinned. From there, the most common progression looks like this:
- Diffuse atrophy: A broad area of thinning spreads across the central retina.
- Lacquer cracks: Linear breaks appear in Bruch’s membrane and tend to widen over time.
- Patchy atrophy: Distinct patches of tissue die off, and these patches enlarge and merge with one another.
- New blood vessel growth: Abnormal vessels break through at any stage, from early tessellation onward.
- Macular atrophy: The final stage, where the central retina degenerates enough to cause significant, often irreversible vision loss.
The fusion of atrophic patches, the growth of new blood vessels, and full macular atrophy all cause the sharpest drops in vision. Not everyone progresses through every stage, and the timeline varies widely, but the general direction is toward greater tissue loss over years and decades.
Who Is Most at Risk
The single strongest predictor is how long and how severely nearsighted your eye is. A meta-analysis of risk factors found that for each additional millimeter of eye length, the odds of developing pathological changes roughly doubled (pooled odds ratio of 2.03). Older age also increases risk, likely because the eye has been under mechanical stress for longer. Higher education level was independently associated with progression, possibly reflecting years of sustained close-up work, though the exact mechanism isn’t settled.
Other factors that appear to play a role, though with less certainty, include higher pressure inside the eye, the severity of existing macular changes, and family history of myopia. Women may be somewhat more likely to develop the condition, and people of East Asian descent appear to be at higher risk, though the evidence on both points is not conclusive. Globally, roughly 10% of the world’s population is projected to have high myopia by 2050, which means the number of people at risk for degenerative complications will grow substantially.
How It Affects Your Vision Day to Day
The hallmark symptom is a gradual loss of central vision, the kind you use for reading, recognizing faces, and driving. Early on, you might notice straight lines appearing wavy or distorted, a phenomenon called metamorphopsia. A door frame might look slightly bent, or the lines on a page may seem to ripple. Blurry spots can develop in the center of your visual field while your peripheral (side) vision stays relatively intact.
If abnormal blood vessels form and leak, the change can be more sudden. You might wake up one morning and notice a new dark or blurry area in the center of your vision that wasn’t there the day before. This is a signal that something has changed and warrants prompt evaluation.
Treatment for Blood Vessel Complications
When new blood vessels invade the retina, the standard treatment involves injections of medication directly into the eye that block the growth signal driving those vessels. These injections work by shutting down the chemical (vascular endothelial growth factor) that tells blood vessels to sprout. A real-world study following patients over 24 months found that vision improved significantly within the first one to six months of treatment. By six months, patients had meaningful gains in visual acuity compared to where they started.
The longer-term picture is more nuanced. After the initial improvement, vision scores tended to stabilize rather than continue climbing, and by 12 months there was no longer a statistically significant difference from baseline in some patients. However, overall gains were generally maintained through the two-year follow-up. The treatment doesn’t reverse existing atrophy or scarring. It targets the active leaking vessels. That’s why early detection matters: treating the vessels before they cause widespread scarring preserves more vision.
For the atrophic changes (thinning and tissue loss without active blood vessel growth), there is currently no treatment that can restore lost tissue. Management focuses on monitoring, maximizing remaining vision with low-vision aids, and catching any new blood vessel growth early.
Monitoring Your Vision at Home
If you’ve been diagnosed with myopic degeneration, regular self-checks between clinic visits can help catch new problems early. The most common tool is the Amsler grid, a simple square grid with a central dot. You cover one eye, focus on the dot, and look for any areas where the lines appear wavy, blurred, or missing. Any new distortion could signal new blood vessel activity or worsening atrophy.
The Amsler grid has limitations. It doesn’t give a precise measurement of how your vision is changing, and real-world compliance tends to be low because it’s easy to forget or skip. Newer smartphone apps have been developed that turn vision testing into a more structured routine. Some use gamified tests of visual sharpness, contrast sensitivity, and distortion detection, and patients are typically asked to use them at least twice a week. These digital tools can track subtle changes over time more precisely than a paper grid, though they still require a prescription and guidance from your eye care provider.
Regardless of the tool, the key habit is the same: check each eye separately on a regular schedule, and note any new distortion, blurriness, or blank spots that appear between your regular eye exams.